<DOC>
	<DOC>NCT02103842</DOC>
	<brief_summary>The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.</brief_summary>
	<brief_title>Omega-3 Fatty Acids to Combat Sarcopenia</brief_title>
	<detailed_description />
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Age 1835 or 6585 years 1. Current use of omega3 nutritional supplements 2. Fasting plasma glucose â‰¥126 mg/dL 3. Active coronary artery disease 4. Participation in structured exercise (&gt;3 times per week for 30 minutes or longer) 5. Smoking 6. Medications known to affect muscle metabolism (e.g., beta blockers, corticosteroids, tricyclicantidepressants, benzodiazepines, opiates, barbiturates, anticoagulants) 7. Renal failure (serum creatinine &gt; 1.5mg/dl) 8. Chronic active liver disease (Bilirubin &gt; 17mmol/L, AST&gt;144IU/L, or ALT&gt;165IU/L) 9. Anticoagulant therapy (warfarin/heparin) 10. INR &gt;3 11. Use of systemic glucocorticoids 12. Chronic use of NSAIDS or aspirin 13. Pregnancy or breastfeeding 14. Alcohol consumption greater than 2 glasses/day 15. Hypothyroidism 16. Fish or shellfish allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>